Protein-ligand docking and virtual screening with GOLD

Virtual Screening in Drug Discovery

Volumn , Issue , 2005, Pages 379-415

  Cole, Jason C ^a   Nissink, J Willem M ^a   Taylor, Robin ^a  

^a CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906467630     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. G. Jones, P. Willett, and R.C. Glen, A genetic algorithm for flexible molecular overlay and pharmacophore elucidation, J. Computer-Aided Mol. Des.9:532-549, 1995;
2. G. Jones, P. Willett, and R.C. Glen, Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation, J. Mol. Biol.245:43-53, 1995;
3. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor, Further development of a genetic algorithm for ligand docking and its application to screening combinatorial libraries. In A.L. Parrill and M.R. Reddy, Eds., Rational Drug Design, ACS Symposium Series, Vol. 719, Washington, D.C.: American Chemical Society, pp. 217-291, 1999.
4. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol.267:727-748, 1997.
5. SYBYL, Tripos, Inc.: Www.tripos.com.
6. A.C. Pierce, K.L. Sandretto, and G.W. Bemis, Kinase inhibitors and the case for CH…O hydrogen bonds in protein-ligand binding, Proteins 49:567-576, 2002;
7. B. Loll, G. Raszewski, W. Saenger, and J. Biesiadka, Functional role of C(alpha)-H…O hydrogen bonds between transmembrane alpha-helices in photosystem, J. Mol. Biol.328:737-747, 2003.
8. I.J. Bruno, J.C. Cole, J.P. Lommerse, R.S. Rowland, R. Taylor, and M.L. Verdonk, IsoStar: A library of information about nonbonded interactions, J. Computer-Aided Mol. Des.11:525-537, 1997.
9. H.J. Bohm, S. Brode, U. Hesse, and G. Klebe, Oxygen and nitrogen in competitive situations: Which is the hydrogen-bond acceptor? Chem. Eur. J.2:1509-1513, 1996;
10. J.D. Dunitz and R. Taylor, Organic fluorine hardly ever accepts hydrogen bonds, Chem. Eur. J.3:89-98, 1997.
11. 2-Systems, Acta. Cryst.B53:696-701, 1997.
12. M. Clark, R.D. Cramer, III, and N. Van Opdenbosch, Validation of the general purpose Tripos 5.2 force field, J. Computer-Aided Mol. Des. 10:982-1012, 1989.
13. M.D. Eldridge, C.W. Murray, T.R. Auton, G.V. Paolini, and R.P. Mee, Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Computer-Aided Mol. Des.11:425-445, 1997.
14. C.A. Baxter, C.W. Murray, D.E. Clark, D.R. Westhead, and M.D. Eldridge, Flexible docking using Tabu search and an empirical estimate of binding affinity, Proteins33:367-382, 1998.
15. M.L. Verdonk, J.C. Cole, M.J. Hartshorn, C.W. Murray, and R.D. Taylor, Improved protein-ligand docking using GOLD, Proteins, 52:609-623, 2003.
16. A.W. Payne and R.C. Glen, Molecular recognition using a binary genetic search algorithm, J. Mol. Graph. 11:74-91, 121-123, 1993.
17. D.E. Goldberg, Genetic Algorithms in Search, Optimization and Machine Learning, Reading, MA: Addison-Wesley, 1989.
18. M.L. Verdonk, J.C. Cole, and R. Taylor, SuperStar: A knowledge-based approach for identifying interaction sites in proteins, J. Mol. Biol.289:1093-1108, 1999;
19. M.L. Verdonk, J.C. Cole, P. Watson, V. Gillet, and P. Willett, SuperStar: Improved knowledge-based interaction fields for protein binding sites, J. Mol. Biol.307:841-859, 2001;
20. D.R. Boer, J. Kroon, J.C. Cole, B. Smith, and M.L. Verdonk, SuperStar: Comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions, J. Mol. Biol.312:275-287, 2001.
21. J.P. Gallivan and D.A. Dougherty, Cation-pi interactions in structural biology, Proc. Natl. Acad. Sci. Usa 96:9459-9464, 1999.
22. F.H. Allen, The Cambridge Structural Database: A quarter of a million crystal structures and rising, Acta. Cryst.B58:380-388, 2002.
23. G. Klebe and T. Mietzner, A fast and efficient method to generate biologically relevant conformations, J. Computer-Aided Mol. Des.8:583-606, 1994.
24. B. Kramer, M. Rarey, and T. Lengauer, Evaluation of the FlexX incremental construction algorithm for protein-ligand docking, Proteins 37:228-241, 1999.
25. Y.P. Pang, E. Perola, K. Xu, and F.G. Prendergast, EUDOC: A computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases, J. Comput. Chem.22:1750-1771, 2001.
26. C.A. Baxter, C.W. Murray, B. Waszkowycz, J. Li, R.A. Sykes, R.G. Bone, T.D. Perkins, and W. Wylie, New approach to molecular docking and its application to virtual screening of chemical databases, J. Chem. Info. Comput. Sci.40:254-262, 2000.
27. T.J. Ewing, S. Makino, A.G. Skillman, and I.D. Kuntz, DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases, J. Computer-Aided Mol. Des.15:411-428, 2001.
28. J.S. Taylor and R.M. Burnett, DARWIN: A program for docking flexible molecules, Proteins 41:173-191, 2000.
29. N.S. Blom and J. Sygusch, High resolution fast quantitative docking using Fourier domain correlation techniques, Proteins 27:493-506, 1997.
30. M. Liu and S. Wang, MCDOCK: A Monte Carlo simulation approach to the molecular docking problem, J. Computer-Aided Mol. Des.13:435-451, 1999.
31. J. Wang, P.A. Kollman, and I.D. Kuntz, Flexible ligand docking: A multistep strategy approach, Proteins 36:1-19, 1999.
32. J.W. Nissink, C. Murray, M. Hartshorn, M.L. Verdonk, J.C. Cole, and R. Taylor, A new test set for validating predictions of protein-ligand interaction, Proteins 49:457-471, 2002.
33. I.N. Shindyalov and P.E. Bourne, An alternative view of protein fold space, Proteins38:247-260, 2000.
34. A. Bergner, J. Gunther, M. Hendlich, G. Klebe, and M. Verdonk, Use of Relibase for retrieving complex three-dimensional interaction patterns including crystallographic packing effects, Biopolymers 61:99-110, 2001.
35. H.B. Broughton, A method for including protein flexibility in protein-ligand docking: Improving tools for database mining and virtual screening, J. Mol. Graphics & Modelling 18:247-257, 302-304, 2000;
36. R. Najmanovich, J. Kuttner, V. Sobolev, and M. Edelman, Side-chain flexibility in proteins upon ligand binding, Proteins39:261-268, 2000;
37. H. Claussen, C. Buning, M. Rarey, and T. Lengauer, Flex E: Efficient molecular docking considering protein structure variations, J. Mol. Biol.308:377-395, 2001;
38. C.H. Li, X.H. Ma, W.Z. Chen, C.X. Wang, A soft docking algorithm for predicting the structure of antibody-antigen complexes, Proteins52:47-50, 2003;
39. C.W. Murray, C.A. Baxter, and A.D. Frenkel, The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, ther-molysin and neuraminidase, J. Computer-Aided Mol. Des.13:547-562, 1999.
40. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem.45:2615-2623, 2002.
41. H.J. Bohm, The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure, J. Computer-Aided Mol. Des.8:243-256, 1994.
42. J. Barbanton, G. Perrot, and S. Salisbury, Multi-processor molecular docking with GOLD, Dechema Assessment Report, 1999.
43. H.J. Bohm, M. Boehringer, D. Bur, H. Gmuender, W. Huber, W. Klaus, D. Kostrewa, H. Kuehne, T. Luebbers, N. Meunier-Keller, and F. Mueller, Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization: A promising alternative to random screening, J. Med. Chem.43:2664-2674, 2000.
44. M. Schapira, B.M. Raaka, H.H. Samuels, and R. Abagyan, Rational discovery of novel nuclear hormone receptor antagonists, Proc. Natl. Acad. Sci. Usa 97:1008-1013, 2000.
45. M. Schapira, R. Abagyan, and M. Totrov, Nuclear hormone receptor targeted virtual screening, J. Med. Chem., 46:3045-3059, 2003.
46. M. Schapira, B.M. Raaka, S. Das, L. Fan, M. Totrov, Z. Zhou, S.R. Wilson, R. Abagyan, and H.H. Samuels, Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking, Proc. Natl. Acad. Sci. Usa 100:7354-7359, 2003.
47. S.C. Hopkins, R.D. Vale, and I.D. Kuntz, Inhibitors of kinesin activity from structure-based computer screening, Biochem. 39:2805-2814, 2000.
48. E. Vangrevelinghe, K. Zimmermann, J. Schoepfer, R. Portmann, D. Fabbro, and P. Furet, Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking, J. Med. Chem.46:2656-2662, 2003.
49. E. Perola, K. Xu, T.M. Kollmeyer, S.H. Kaufmann, F.G. Prendergast, and Y.P. Pang, Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads, J. Med. Chem.43:401-408, 2000.
50. B. Waskowycz, T.D.J. Perkins, R.A. Sykes, and J. Li, Large-scale virtual screening for discovering leads in the postgenomic era, IBM Systems 40:360-376, 2001.
51. C. Bissantz, G. Folkers, and D. Rognan, Protein-based virtual screening of chemical databases: 1. Evaluation of different docking/scoring combinations, J. Med. Chem.43:4759-4767, 2000.
52. M.L. Verdonk, V. Berdini, M.J. Hartshorn, W.T.M. Mooij, C.W. Murray, R.D. Taylor, and P. Watson, Virtual screening using protein-ligand docking: Avoiding artificial enrichment, J. Chem. Info. Comput. Sci.44:793-806, 2004.
53. J.L. Jenkins, R.Y. Kao, and R. Shapiro, Virtual screening to enrich hit lists from high-throughput screening: A case study on small-molecule inhibitors of angiogenin, Proteins50:81-93, 2003.
54. I.J. Mcfadyen, H. Houshyar, L.Y. Liu-Chen, J.H. Woods, and J.R. Traynor, The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: Implications for the mu-opioid pharmacophore, Mol. Pharmacol.58:669-676, 2000.
55. L. Afzelius, I. Zamora, M. Ridderstrom, T.B. Andersson, A. Karlen, and C.M. Masimirembwa, Competitive CYP2C9 inhibitors: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis, Mol. Pharmacol.59:909-919, 2001.
56. A. Logean, A. Sette, and D. Rognan, Customized versus universal scoring functions: Application to class I MHC-peptide binding free energy predictions, Bioorg. Med. Chem. Lett.11:675-679, 2001.
57. R. Wang, Y. Lu, and S. Wang, Comparative evaluation of 11 scoring functions for molecular docking, J. Med. Chem.46:2287-2303, 2003.
58. G.M. Keseru, A virtual high throughput screen for high affinity cytochrome P450cam substrates: Implications for in silico prediction of drug metabolism, J. Computer-Aided Mol. Des.15:649-657, 2001.
59. R.D. Clark, A. Strizhev, J.M. Leonard, J.F. Blake, and J.B. Matthew, Consensus scoring for ligand/protein interactions, J. Mol. Graphics & Modelling 20:281-295, 2002.
60. N. Paul and D. Rognan, ConsDock: A new program for the consensus analysis of protein-ligand interactions, Proteins 47:521-533, 2002.
61. G.E. Terp, B.N. Johansen, I.T. Christensen, and F.S. Jorgensen, A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities, J. Med. Chem.44:2333-2343, 2001.
62. W.P. Van Hoorn, Identification of a second binding site in the estrogen receptor, J. Med. Chem.45:584-589, 2002.
63. A. Clemente, A. Domingos, A.P. Grancho, J. Iley, R. Moreira, J. Neres, N. Palma, A.B. Santana, and E. Valente, Design, synthesis and stability of N-acyloxymethyl- and N-aminocarbonyloxymethyl-2-azetidinones as human leukocyte elastase inhibitors, Bioorg. Med. Chem. Lett.11:1065-1068, 2001.
64. C. Bissantz, P. Bernard, M. Hibert, and D. Rognan, Protein-based virtual screening of chemical databases: Ii. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 50:5-25, 2003.
65. M. Hendlich, F. Rippmann, and G. Barnickel, LIGSITE: Automatic and efficient detection of potential small molecule-binding sites in proteins, J. Mol. Graphics & Modelling15:359-363, 389, 1997.
66. J.S. Delaney, Finding and filling protein cavities using cellular logic operations, J. Mol. Graph.10:174-177, 163, 1992.
67. S.A. Hindle, M. Rarey, C. Buning, and T. Lengauer, Flexible docking under pharmacophore type constraints, J. Computer-Aided Mol. Des.16:129-149, 2002.
68. X. Fradera, R.M. Knegtel, and J. Mestres, Similarity-driven flexible ligand docking, Proteins 40:623-636, 2000.
69. A.C. Good, E.E. Hodgkin, and W.G. Richards, Utilization of Gaussian functions for the rapid evaluation of molecular similarity, J. Chem. Info. Comput. Sci.32:188-191, 1992.
70. C.A. Lesburg, C. Huang, D.W. Christianson, and C.A. Fierke, Histidine --> carboxamide ligand substitutions in the zinc binding site of carbonic anhydrase II alter metal coordination geometry but retain catalytic activity, Biochem. 36:15780-15791, 1997.
71. D.K. Wilson, T. Nakano, J.M. Petrash, and F.A. Quiocho, 1.7 A structure of FR-1, a fibroblast growth factorinduced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor, Biochem. 34:14323-14330, 1995.
72. A. Geist, A. Beguelin, J. Dongarra, J. Weicheng, R. Manchek, and V. Sunderam. In J. Kowalik, Ed., PVM: Parallel Virtual Machine. A User’s Guide and Tutorial for Networked Parallel Computing, Cambridge, MA: Mit Press, 1994.
73. CTfile Formats. In MDL Information Systems: Mdl User Documentation, MDL, 2001.
74. J.C. Cole, J.W.M. Nissink, and R. Taylor, Gold Scoring-Function A.P.I. Documentation. In Gold Online Documentation v2-1, CCDC, 2003.